Page 1

STRATA Skin Sciences Reports Second Quarter 2021 Financial Results Exhibit 99.1 Horsham , Pa , August 16 , 2021 —STRATA Skin Sciences , Inc. ( NASDAQ : SSKN ) , a medical technology company dedicated to developing , commercializing , and marketing innovative products for the treatment of dermatologic conditions , today announced financial results for the quarter ended June 30 , 2021 . Recent Highlights Total revenue for the second quarter of 2021 was $ 7.4 million , an increase of 83.1 % as compared to the second quarter of 2020 Recurring revenue for the second quarter of 2021 was $ 5.5 million , a 95.0 % increase over the second quarter of 2020 Gross domestic recurring billings were $ 5.5 million , a 196.6 % increase over the second quarter 2020 ( See Reconciliation of Non - GAAP measures below ) Total gross margins in the second quarter of 2021 were 64.5 % , a 15.8 % increase over second quarter 2020 Cash , cash equivalents and restricted cash at June 31 , 2021 were $ 17.0 million down from 17.5 million at March 31 , 2021 Concluded the quarter with a global recurring revenue installed base of 889 XTRAC devices , an increase of 18 devices from March 31 , 2021 Acquired U.S. dermatology business of Ra Medical Systems , significantly expanding opportunity to generate additional recurring revenue and expand customer base Hired New VP of Marketing , Brent Cowgill Received notification of Paycheck Protection Program loan forgiveness " We were encouraged by our second quarter results , which showed significant growth over the second quarter of 2020 , but more importantly , reflect total revenues at 95 % of the comparable quarter of 2019 levels , " said Robert J. Moccia , Chief Executive Officer of STRATA Skin Sciences . " Additionally , we've seen significant progress on our new strategic plan approved by our Board in May , including the positive impact of our improved direct to consumer and direct to dermatologist marketing efforts , as well as the successful execution of our sales initiatives . We were also pleased to announce the acquisition of the Pharos 308nm excimer laser business from Ra Medical . This transaction further demonstrates our commitment to commercial execution to drive both organic and inorganic growth , " continued Mr. Moccia . " In addition , Brent Cowgill recently joined the STRATA team , heading up our marketing efforts . We are confident that his extensive experience in sales and marketing will further enable us to reach new customers and expand the XTRAC excimer laser's patient and physician base . " Second Quarter 2021 Financial Results Revenues were $ 7.4 million , as compared to revenues of $ 4.0 million for the second quarter of 2020. Recurring revenues were $ 5.5 million , as compared to recurring revenues of $ 2.8 million for the second quarter of 2020. Equipment revenues were $ 1.9 million , as compared to $ 1.2 million for the second quarter of 2020 . Gross profit was $ 4.8 million , or 64.5 % of revenues , as compared to $ 2.0 million , or 48.7 % of revenues , for the second quarter of 2020. Gross profit on recurring revenues was $ 3.8 million , or 70.0 % of recurring revenues , as compared to $ 1.4 million , or 51.2 % of revenues , for the second quarter of 2020. The increase in gross profit is the result of higher sales , partially offset by higher depreciation expense .